Article, 2024

LB-001 Semaglutide 2.4 mg efficacy and safety in people with obesity and knee osteoarthritis: Results: from the STEP 9 randomised clinical trial

Osteoarthritis and Cartilage, ISSN 1522-9653, 1063-4584, Volume 32, 6, Pages 745-746, 10.1016/j.joca.2024.03.003

Contributors

Bliddal, Henning 0000-0002-7951-1668 [1] Bays, Harold Edward 0000-0001-9912-1408 [2] Czernichow, Sébastien 0000-0001-7353-2532 [3] Hemmingsson, Joanna Uddén 0000-0002-0126-4257 [4] Hjelmesæth, Jøran [5] Morville, Thomas Hoffmann 0000-0002-9039-2591 [6] Koroleva, Anna [6] Neergaard, Jesper Skov 0000-0002-3034-8038 [6] Wharton, Sean [7] Wizert, Alicja Ewa [6] Kristensen, Lars Erik 0000-0003-1159-3721 [1]

Affiliations

  1. [1] Bispebjerg and Frederiksberg Hospital
    2. [NORA names: Capital Region of Denmark; Hospital; Denmark; Europe, EU; Nordic; OECD];
  2. [2] Louisville Metabolic and Atherosclerosis Research Center
    3. [NORA names: United States; America, North; OECD];
  3. [3] Université Paris Cité
    4. [NORA names: France; Europe, EU; OECD];
  4. [4] Obesity Department, Capio St. Görans Hospital, and the Karolinska Institute, Stockholm, Sweden
    5. [NORA names: Sweden; Europe, EU; Nordic; OECD];
  5. [5] Sykehuset i Vestfold
    6. [NORA names: Norway; Europe, Non-EU; Nordic; OECD];

Keywords

clinical trials, efficacy, knee, knee osteoarthritis, obesity, osteoarthritis, people, results, safety, semaglutide, steps, trials

Data Provider: Digital Science

LINKS
-

Matching Records in NORA

  • No Matches Found

SUBJECTS
+

METRICS
+